Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation ; day:7 ; month:1 ; year:2022 ; pages:1-8
Clinical research in cardiology ; (7.1.2022), 1-8
- Urheber
-
Ding, Wern Yew
Rivera-Caravaca, José Miguel
Fazio-Eynullayeva, Elnara
Underhill, Paula
Gupta, Dhiraj
Marín, Francisco
Lip, Gregory Y. H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-021-01983-z
- URN
-
urn:nbn:de:101:1-2022042410094074712213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ding, Wern Yew
- Rivera-Caravaca, José Miguel
- Fazio-Eynullayeva, Elnara
- Underhill, Paula
- Gupta, Dhiraj
- Marín, Francisco
- Lip, Gregory Y. H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Managing high-risk atrial fibrillation patients with multiple comorbidities
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Management of Device Detected Subclinical Atrial Fibrillation
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future
Introducing Our New Offspring Journal … TH Open
A Happy New Year from a 60-Year-Old Journal ‘Thrombosis and Haemostasis’!
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Managing high-risk atrial fibrillation patients with multiple comorbidities
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Management of Device Detected Subclinical Atrial Fibrillation
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future
Introducing Our New Offspring Journal … TH Open
A Happy New Year from a 60-Year-Old Journal ‘Thrombosis and Haemostasis’!
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Managing high-risk atrial fibrillation patients with multiple comorbidities
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Management of Device Detected Subclinical Atrial Fibrillation
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future
Introducing Our New Offspring Journal … TH Open
A Happy New Year from a 60-Year-Old Journal ‘Thrombosis and Haemostasis’!